Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Pediatric Hematology
•
ITP
What work-up should be performed, if any, for a young child with chronic ITP?
Related Questions
How do you approach a persistently elevated mean platelet volume and immature platelet fraction in an otherwise healthy patient with a normal platelet count?
Are there any circumstances where you would consider bridging for patients on DOACs?
Are SCDs contraindicated in patients with acute DVTs?
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?
When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
Do you screen children with sickle cell disease for silent cerebral infarcts?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?